BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 27935134)

  • 1. Strain- and time-dependent alterations in hepatic iron metabolism in a murine model of nonalcoholic steatohepatitis.
    Bloomer SA; Olivier AK; Bergmann OM; Mathahs MM; Broadhurst KA; Hicsasmaz H; Brown KE
    Cell Biochem Funct; 2016 Dec; 34(8):628-639. PubMed ID: 27935134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice.
    Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M
    Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice.
    Yamamoto T; Nakade Y; Yamauchi T; Kobayashi Y; Ishii N; Ohashi T; Ito K; Sato K; Fukuzawa Y; Yoneda M
    World J Gastroenterol; 2016 Feb; 22(8):2512-23. PubMed ID: 26937139
    [TBL] [Abstract][Full Text] [Related]  

  • 4.  Differences in hepatic expression of iron, inflammation and stress-related genes in patients with nonalcoholic steatohepatitis.
    Handa P; Vemulakonda AL; Maliken BD; Morgan-Stevenson V; Nelson JE; Dhillon BK; Hennessey KA; Gupta R; Yeh MM; Kowdley KV
    Ann Hepatol; 2017 Jan-Feb 2017; 16(1):77-85. PubMed ID: 28051796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.
    Matsuzawa N; Takamura T; Kurita S; Misu H; Ota T; Ando H; Yokoyama M; Honda M; Zen Y; Nakanuma Y; Miyamoto K; Kaneko S
    Hepatology; 2007 Nov; 46(5):1392-403. PubMed ID: 17929294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high-fat diet modulates iron metabolism but does not promote liver fibrosis in hemochromatotic Hjv⁻/⁻ mice.
    Padda RS; Gkouvatsos K; Guido M; Mui J; Vali H; Pantopoulos K
    Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G251-61. PubMed ID: 25501544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p16 deficiency promotes nonalcoholic steatohepatitis via regulation of hepatic oxidative stress.
    Lv F; Wu J; Miao D; An W; Wang Y
    Biochem Biophys Res Commun; 2017 Apr; 486(2):264-269. PubMed ID: 28286271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenetic protein-binding endothelial regulator of liver sinusoidal endothelial cells induces iron overload in a fatty liver mouse model.
    Hasebe T; Tanaka H; Sawada K; Nakajima S; Ohtake T; Fujiya M; Kohgo Y
    J Gastroenterol; 2017 Mar; 52(3):341-351. PubMed ID: 27364348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ezetimibe increases hepatic iron levels in mice fed a high-fat diet.
    Kishino Y; Tanaka Y; Ikeda T; Yamamoto K; Ogawa H; Iwatani Y; Kamisako T
    J Pharmacol Exp Ther; 2013 Jun; 345(3):483-91. PubMed ID: 23538201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.
    Simon Y; Kessler SM; Gemperlein K; Bohle RM; Müller R; Haybaeck J; Kiemer AK
    World J Gastroenterol; 2014 Dec; 20(47):17839-50. PubMed ID: 25548482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice.
    Kubota N; Kado S; Kano M; Masuoka N; Nagata Y; Kobayashi T; Miyazaki K; Ishikawa F
    Clin Exp Pharmacol Physiol; 2013 Jul; 40(7):422-30. PubMed ID: 23611112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
    Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
    Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.
    Liu C; Schönke M; Spoorenberg B; Lambooij JM; van der Zande HJP; Zhou E; Tushuizen ME; Andreasson AC; Park A; Oldham S; Uhrbom M; Ahlstedt I; Ikeda Y; Wallenius K; Peng XR; Guigas B; Boon MR; Wang Y; Rensen PCN
    Elife; 2023 Jan; 12():. PubMed ID: 36648330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis.
    Gutschow P; Schmidt PJ; Han H; Ostland V; Bartnikas TB; Pettiglio MA; Herrera C; Butler JS; Nemeth E; Ganz T; Fleming MD; Westerman M
    Haematologica; 2015 Feb; 100(2):167-77. PubMed ID: 25425686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gliptins Suppress Inflammatory Macrophage Activation to Mitigate Inflammation, Fibrosis, Oxidative Stress, and Vascular Dysfunction in Models of Nonalcoholic Steatohepatitis and Liver Fibrosis.
    Wang X; Hausding M; Weng SY; Kim YO; Steven S; Klein T; Daiber A; Schuppan D
    Antioxid Redox Signal; 2018 Jan; 28(2):87-109. PubMed ID: 28635324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron overload results in hepatic oxidative stress, immune cell activation, and hepatocellular ballooning injury, leading to nonalcoholic steatohepatitis in genetically obese mice.
    Handa P; Morgan-Stevenson V; Maliken BD; Nelson JE; Washington S; Westerman M; Yeh MM; Kowdley KV
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(2):G117-27. PubMed ID: 26564716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Ding Y; Sun X; Chen Y; Deng Y; Qian K
    Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation neither increases hepatic hepcidin nor affects intestinal (59)Fe-absorption in two murine models of bowel inflammation, hemizygous TNF(ΔARE/+) and homozygous IL-10(-/-) mice.
    Buffler M; Becker C; Windisch W; Schümann K
    J Trace Elem Med Biol; 2015 Oct; 32():162-7. PubMed ID: 26302924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.